A Study of DXC008 in Patients With Prostate Cancer and Other Solid Tumors

NCT06926283 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer
Other Solid Tumors
Ewing Sarcoma

Interventions

DRUG: DXC008

Sponsor

Hangzhou DAC Biotechnology Co., Ltd.